U

US BioTec Inc
OTC:USBC

Watchlist Manager
US BioTec Inc
OTC:USBC
Watchlist
Price: 0.59 USD -1.67%
Market Cap: 226.7m USD

Relative Value

USBC doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of USBC.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

USBC Relative Value
Base Case
Not Available
U
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.2
vs History
vs Industry
Median 3Y
-0
Median 5Y
0
Industry
24.2
vs History
vs Industry
Median 3Y
-0
Median 5Y
0
Industry
23
vs History
vs Industry
Median 3Y
-0
Median 5Y
0
Industry
25.5
vs History
vs Industry
Median 3Y
-0
Median 5Y
0
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
6.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
6.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
6.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.7

Multiples Across Competitors

USBC Competitors Multiples
US BioTec Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
US BioTec Inc
OTC:USBC
225.1m USD 0 0 0 0
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 170 980.7 -162 409.6 -197 217.1 -194 966.6
US
Abbvie Inc
NYSE:ABBV
379.8B USD 6.4 161.8 15.8 22.4
US
Amgen Inc
NASDAQ:AMGN
176.7B USD 4.9 25.2 18.2 18.2
US
Gilead Sciences Inc
NASDAQ:GILD
153.3B USD 5.3 18.9 12.7 12.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.7B USD 9.6 30.7 22.5 23.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 061.7 -526.1 -572.9 -557.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.6B USD 5.4 16.9 16.1 18.3
AU
CSL Ltd
ASX:CSL
85B AUD 3.7 19 12.8 16
NL
argenx SE
XBRU:ARGX
43.3B EUR 13.9 32.8 56.4 58
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD 14.7 1 085.6 148.6 180.2
P/S Multiple
Revenue Growth P/S to Growth
US
U
US BioTec Inc
OTC:USBC
Average P/S: 3 417 310.6
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 170 980.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.4
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.3
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.6
10%
1
US
E
Epizyme Inc
F:EPE
2 061.7
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.4
6%
0.9
AU
CSL Ltd
ASX:CSL
3.7
5%
0.7
NL
argenx SE
XBRU:ARGX
13.9
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
14.7
46%
0.3
P/E Multiple
Earnings Growth PEG
US
U
US BioTec Inc
OTC:USBC
Average P/E: 173.9
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 409.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
161.8
89%
1.8
US
Amgen Inc
NASDAQ:AMGN
25.2
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.9
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.7
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -526.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
10%
1.7
AU
CSL Ltd
ASX:CSL
19
11%
1.7
NL
argenx SE
XBRU:ARGX
32.8
40%
0.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 085.6
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
U
US BioTec Inc
OTC:USBC
Average EV/EBITDA: 37.9
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 217.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.8
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
18.2
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.5
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
11%
1.5
AU
CSL Ltd
ASX:CSL
12.8
8%
1.6
NL
argenx SE
XBRU:ARGX
56.4
810%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
148.6
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
U
US BioTec Inc
OTC:USBC
Average EV/EBIT: 43.6
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 966.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.4
30%
0.7
US
Amgen Inc
NASDAQ:AMGN
18.2
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.7
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.3
13%
1.4
AU
CSL Ltd
ASX:CSL
16
11%
1.5
NL
argenx SE
XBRU:ARGX
58
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
180.2
N/A N/A